A New Era of Precision Imaging for Venous Thromboembolism – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jamal Elhasnaoui et al., adding:
“Nuclear molecular imaging of venous thromboembolism: targeting clot-specific molecular components for improved diagnosis and management
Today’s clot imaging shows structure and perfusion but little about clot biology. This review surveys nuclear molecular imaging that targets clot-specific components, using PET to read molecular processes in living tissue.
Paired with high-throughput methods, such approaches could yield precision imaging biomarkers and move venous thromboembolism care toward molecularly informed diagnosis and treatment.”
Title: Nuclear molecular imaging of venous thromboembolism: targeting clot-specific molecular components for improved diagnosis and management
Authors: Jamal Elhasnaoui, Philippe Robin, Catherine A. Lemarie
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe LippiÖ‰ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question